IForce Nutrition | IFN Hemavol Tablets | 32 Capsules

IFN Hemavol Tablets is a classic stim-free pump formula built around one central idea: better training sessions start with better blood flow, better cellular hydration, and sharper neuromuscular engagement. Instead of chasing energy with caffeine, this formula stacks multiple nitric oxide and vasodilation-adjacent ingredients to increase fullness, improve the feeling of contraction, and support work capacity during higher-volume lifting. In category terms, that makes it a dedicated pump product rather than a full-spectrum performance pre-workout.

The core issue—and the core truth customers should know—is transparency. Hemavol uses proprietary blends, so the exact amounts of citrulline malate, glyceryl monostearate, agmatine sulfate, norvaline, Alpha-GPC, rutacarpine, and epimedium are not disclosed on the verified tablet label. That means we can explain the physiology with confidence, but we cannot verify whether each ingredient reaches its best-studied standalone dose.

Citrulline malate is the anchor ingredient here. Citrulline is converted to arginine in the kidneys more effectively than oral arginine itself, which then supports nitric oxide synthesis and vasodilation. In practical terms, that means more blood delivery to working muscle, better pumps, and often a stronger sense of muscular endurance in moderate-to-high rep training. Clinical pre-workout research on citrulline typically lands around 6-8 grams of citrulline malate or comparable citrulline dosing; because Hemavol hides the exact amount inside a 4.1 g matrix shared with three other ingredients, we cannot call this a confirmed clinical dose.

Glyceryl monostearate is included for glycerol-driven hyperhydration support. The intended experience is a denser, rounder pump through improved fluid retention in muscle tissue, especially when users train well hydrated. Agmatine sulfate adds another layer to the pump strategy. Agmatine is a decarboxylated arginine metabolite commonly used in pump formulas for its nitric oxide-modulating and neuromodulatory effects; users often describe it as deepening pumps and improving training feel. Norvaline is theoretically included as an arginase inhibitor, which could help reduce arginine breakdown and prolong nitric oxide availability. Evidence here is limited, and this is one of the more speculative components in modern pump formulas, but the formulator's logic is clear: increase NO substrate with citrulline, then try to preserve that pathway with norvaline.

The secondary blend adds L-alpha-glycerylphosphorylcholine, a choline donor commonly used to support acetylcholine production and mind-muscle connection. That choice makes sense in a pump-focused formula because better contraction quality often amplifies the subjective value of increased blood flow. Rutacarpine is more unusual. The evidence base is emerging and largely preclinical, with reported cardiovascular and vasorelaxant effects in animal and in vitro models; it is not a mainstream performance staple. Epimedium extract is another non-core addition with low-to-moderate evidence overall and limited direct relevance to acute workout performance at an undisclosed dose.

The vitamin additions are minor but purposeful. Vitamin C contributes basic antioxidant support, niacin can contribute a flush or warming sensation in some users, and methylcobalamin B12 is present at a high label amount, though B12 is not the driver of the workout effect here.

As a system, Hemavol aims to create a layered pump: citrulline for arginine-NO support, glycerol for cell hydration, agmatine for pump modulation, norvaline for theoretical arginine preservation, and Alpha-GPC for better contraction quality. Day 1, users should expect improved fullness and workout feel rather than stimulant energy. Over 2-4 weeks, the experience is less about loading and more about repeatable execution—you learn how it pairs with hydration, carb intake, and higher-volume training to consistently produce better pumps. The formula concept is strong for its era. The limiting factor is proprietary blending, which prevents a true milligram-by-milligram clinical audit.

How to Use IFN Hemavol Tablets